Phreesia, Inc. (NYSE:PHR) General Counsel Sells $105,961.02 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,982 shares of Phreesia stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $105,961.02. Following the completion of the transaction, the general counsel now owns 159,137 shares of the company’s stock, valued at approximately $4,234,635.57. The trade was a 2.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Phreesia Price Performance

Shares of PHR traded up $1.44 during trading hours on Wednesday, hitting $28.42. 668,317 shares of the company were exchanged, compared to its average volume of 410,783. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. The company has a market capitalization of $1.65 billion, a PE ratio of -19.33 and a beta of 0.94. The firm has a fifty day simple moving average of $22.30 and a 200-day simple moving average of $22.49. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same period last year, the company posted ($0.58) earnings per share. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analyst Weigh In

PHR has been the topic of a number of research reports. Truist Financial increased their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Robert W. Baird dropped their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price objective for the stock from $24.00 to $32.00 in a report on Wednesday. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Eleven research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $30.64.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Deerfield Management Company L.P. Series C purchased a new position in Phreesia during the second quarter valued at approximately $4,078,000. Champlain Investment Partners LLC lifted its position in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the last quarter. Sei Investments Co. lifted its position in shares of Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares during the last quarter. Squarepoint Ops LLC boosted its stake in Phreesia by 56.3% during the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares during the period. Finally, State Street Corp grew its holdings in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.